Position in LLY
as of Jun 30, 2026
· filed Aug 3, 2026
Position Value
$658,487
+$102,027 QoQ
Shares Held
549
-9.3% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.28%
of 13F equity value
Holder Rank
#3,515
of 4,605 holders
Holding Since
Jun 2025
5 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in LLY Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Manske Wealth Management holds $11,013,103 across 10 Drug Manufacturers - General names. LLY ranks #7 (6.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | MRK |
Merck & Co., Inc.
|
15,455 | $1,985,967 | |
| 2 | GSK |
GSK plc
|
37,767 | $1,979,746 | |
| 3 | BMY |
Bristol Myers Squibb Co
|
23,392 | $1,347,847 | |
| 4 | PFE |
Pfizer Inc
|
53,019 | $1,276,697 | |
| 5 | NVO |
Novo Nordisk A S
|
24,546 | $1,176,735 | |
| 6 | GILD |
Gilead Sciences, Inc.
|
8,591 | $1,085,386 | |
| 7 | LLY |
ELI LILLY & Co
This page
|
549 | $658,487 | |
| 8 | JNJ |
Johnson & Johnson
|
2,186 | $555,178 |
All Filings in LLY
Export CSV
5 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $658,487 | 549 | Shares | Sole | 2026-08-03 | |
| 2026-03-31 | $556,460 | 605 | Shares | Sole | 2026-04-30 | |
| 2025-12-31 | $511,547 | 476 | Shares | Sole | 2026-02-03 | |
| 2025-09-30 | $341,824 | 448 | Shares | Sole | 2025-11-12 | |
| 2025-06-30 | $340,654 | 437 | Shares | Sole | 2025-11-12 | |
| No filing history on record for this holder in this stock. | ||||||